New MSc in Precision Cancer Medicine

Cancer Researchers at the University of Oxford have launched a two-year, part-time, online course in Precision Cancer Medicine. The new course is an exciting opportunity for professionals from across the research, clinical and medical spheres to learn more about how to make precision medicine a reality.

About precision medicine

Precision medicine is a novel approach to patient care, which allows medical professionals to select specific treatments that are most likely to help with their cancer.

It considers the genetics of the cancer, the patient’s biology, environment and lifestyle, in order to guide disease diagnosis and treatment. It is also known as personalised or tailored treatment.

Most cancer treatments take a ‘one-size fits all’ approach, such as using chemotherapy drugs across the whole body to kill cancerous cells. Often these drugs do not differentiate between cancer and non-cancer cells in the body, which may cause unpleasant side effects that can have long-lasting implications.

By creating tailored treatments that target the specific cancer cells we can improve patient experiences of cancer treatment and reduce these side effects.

About the course

The new Masters course hopes to equip graduates with a multi-disciplinary understanding, beyond their own area of expertise, and prepare them for roles at the forefront of cancer medicine.

It will touch on areas such as cancer genomics, pathology, omics techniques, diagnostics, experimental therapeutics, onco-immunology, bioinformatics, ethics and health economics.

For more information about the course, see here.